Biocon Ltd. NSE: BIOCON | BSE: 532523

Biocon Ltd. Live Share Price Today, Share Analysis and Chart

316.55 10.25 (3.35%)

3.3M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

US FDA Approval
Biocon receives USFDA approval for Jobevne, used in cancer treatment, with a market size of ~$2 bn See details
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Medium Financial Strength
55.0 / 100
Mid Valuation
39.8 / 100
Technically Bearish
32.6 / 100
Slowing Down Stock These stocks score good in Quality and also have medium range financials. However, a bad technical scoring and bearish aspects decrease the investor's interest over time. View Similar Embed DVM

Biocon Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

Annual Report Mar-2024
Annual Report Mar-2023
Annual Report Mar-2022
Annual Report Mar-2021
Annual Report Mar-2020
Annual Report Mar-2019
Annual Report Mar-2018
Annual Report Mar-2017
Annual Report Mar-2016
Annual Report Mar-2015
Annual Report Mar-2014
Annual Report Mar-2013
Annual Report Mar-2012

Biocon Ltd. FAQ

How is Biocon Ltd. today?
Biocon Ltd. today is trading in the green, and is up by 3.35% at 316.55.
Biocon Ltd. is currently trading up 3.35% on an intraday basis. In the past week the stock fell -3.43%. stock has been down -12.30% in the past quarter and rose 15.53% in the past year. You can view this in the overview section.